United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022

United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022.
 
 Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness, lack of device education and training among physicians and perception of the higher cost is expected to hamper growth of the market during forecast period.
 
 “United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pen Market.
 
 The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.
 
 Key Topics Covered in the Report
 
 • United States Diabetes Population (2011 – 2022)
 • United States Insulin Users (2011 – 2022)
 • United States Insulin Pen Users (2011 – 2022)
 • United States Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
 • United States Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
 • United States Insulin Pen Market (2011 – 2022)
 • United States Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
 • United States Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
 • United States Insulin Pen Market: Reimbursement & Regulation System
 • Key Companies Analysis
 • Key Drivers and Inhibitors of the United States Insulin Pen Market
 
 Key Companies Covered in the Report are as follows:
 
 • Novo Nordisk
 • Eli Lilly
 • Sanofi
 • Owen Mumford

 1. Executive Summary
 
 2. United States Diabetes Population & Insulin Users Analysis (2011 – 2022)
 2.1 Overall Diabetes Population
 2.2 Insulin Users
 
 3. United States – Insulin Pen Users Trend & Analysis (2011 – 2022)
 3.1 Insulin Pen Users & Forecast
 3.1.1 Reusable (Cartridge) Insulin Pen Users
 3.1.2 Prefilled (Disposable) Insulin Pen Users
 3.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share
 
 4. United States – Insulin Pen Market Trend & Analysis (2011 – 2022)
 4.1 Insulin Pen Market & Forecast
 4.1.1 Reusable (Cartridge) Insulin Pen Market
 4.1.2 Prefilled (Disposable) Insulin Pen Market
 4.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share
 
 5. Key Drivers and Inhibitors of the United States Insulin Pen Market
 5.1 Market Drivers
 5.2 Inhibitors
 
 6. United States Insulin Pen Market: Reimbursement & Regulation System
 6.1 Reimbursement System
 6.2 Regulation System
 
 7. Key Companies Analysis
 7.1 Novo Nordisk
 7.1.1 Business Overview
 7.1.2 Insulin Pen – Products Portfolio
 7.1.3 Insulin Pen – Latest Development & Trends
 7.2 Eli Lilly
 7.2.1 Business Overview
 7.2.2 Insulin Pen – Products Portfolio
 7.2.3 Insulin Pen – Latest Development & Trends
 7.3 Sanofi
 7.3.1 Business Overview
 7.3.2 Insulin Pen – Products Portfolio
 7.4 Owen Mumford
 7.4.1 Business Overview
 7.4.2 Insulin Pen – Products Portfolio

List Of Tables

 Table 3–1: United States – Insulin Pen Users Share(Percent),2011 – 2016
 Table 3–2: United States – Forecast for Insulin Pen Users Share(Percent),2017 – 2022
 Table 4–1: United States – Insulin Pen Market Share(Percent),2011 – 2016
 Table 4–2: United States – Forecast for Insulin Pen Market Share(Percent),2017 – 2022
 Table 5–2: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040
  

List Of Figures

 Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
 Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
 Figure 2–3: United States – Insulin Users(Thousand),2011 – 2016
 Figure 2–4: United States – Forecast for Insulin Users(Thousand),2017 – 2022
 Figure 3–1: United States – Overall Insulin Pen Users (Thousand), 2011 – 2016
 Figure 3–2: United States – Forecast for Overall Insulin Pen Users (Thousand), 2017 – 2022
 Figure 3–3: United States – Reusable Insulin Pen Users (Thousand), 2011 – 2016
 Figure 3–4: United States – Forecast for Reusable Insulin Pen Users (Thousand), 2017 – 2022
 Figure 3–5: United States – Prefilled Insulin Pen Users (Thousand), 2011 – 2016
 Figure 3–6: United States – Forecast for Prefilled Insulin Pen Users (Thousand), 2017 – 2022
 Figure 4–1: United States – Insulin Pen Market (Million US$), 2011 – 2016
 Figure 4–2: United States – Forecast for Insulin Pen Market (Million US$), 2017 – 2022
 Figure 4–3: United States – Reusable Insulin Pen Market (Million US$), 2011 – 2016
 Figure 4–4: United States – Forecast for Reusable Insulin Pen Market (Million US$), 2017 – 2022
 Figure 4–5: United States – Prefilled Insulin Pen Market (Million US$), 2011 – 2016
 Figure 4–6: United States – Forecast for Prefilled Insulin Pen Market (Million US$), 2017 – 2022
 
 Companies Mentioned
 
 Novo Nordisk,
 Eli Lilly,
 Sanofi,
 Owen Mumford

Fill The Form For Sample Request

There is no Reviews available